A drug used with lenalidomide and dexamethasone to treat multiple myeloma. It is used in patients who received at least one other anticancer treatment. It is also being studied in the treatment of other types of cancer. Ixazomib citrate blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called Ninlaro. US Brand Name(s): Ninlaro. FDA Approved: Yes
Are you looking for or in search of FDA approved “ixazomib capsules in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for multiple myeloma. Need Access of “ixazomib capsules” for oral use for oral use, get in touch with our healthcare professional.
Ixazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, a type of white blood cell cancer, in combination with other drugs. It is taken by mouth in the form of capsules.
The drug was developed by Takeda. In the US, it is approved since November 2015, and in the EU since November 2016.
Use in Cancer
Ixazomib citrate is approved to be used with lenalidomide and dexamethasone to treat:
Multiple myeloma in patients who have already received at least one other type of treatment.
Ixazomib citrate is also being studied in the treatment of other types of cancer.